Change - Announcement of Cessation::CESSATION AS CHIEF EXECUTIVE OFFICER
Issuer & Securities
MEDTECS INTERNATIONAL CORP LTD
MEDTECS INTERNATIONAL CORP LTD - BMG5958R1043 - 546
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
CESSATION AS CHIEF EXECUTIVE OFFICER
Submitted By (Co./ Ind. Name)
CLEMENT YANG KER-CHENG
Description (Please provide a detailed description of the event in the box below)
Mr William Weiyuan ("Mr William Yang") replaced Mr Clement Yang Ker-Cheng ("Mr Clement Yang") as the Chief Executive Officer of Medtecs International Corporation Limited (the "Company") with effect from 2 May 2018.
Mr Clement Yang remains as the Executive Chairman of the Company.
This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, R & T Corporate Services Pte. Ltd. ("Sponsor"), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("Exchange"). The Sponsor has not independently verified the contents of this announcement including the accuracy or completeness of any of the figures used, statements, opinions or other information made or disclosed.
This announcement has not been examined or approved by the Exchange. The Sponsor and the Exchange assume no responsibility for the contents of this announcement including the correctness of any of the statements or opinions made or reports contained in this announcement.
The contact persons for the Sponsor are Ms Evelyn Wee (Telephone Number: +65 6232 0724) and Mr Howard Cheam Heng Haw (Telephone Number: +65 6232 0685), R & T Corporate Services Pte. Ltd., at 9 Battery Road #25-01, Singapore 049910.
Name Of Person
Clement Yang Ker-Cheng
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
As part of the Medtecs Group's management succession planning to ensure continuity of leadership. Based on the Sponsor's enquiries of Mr Clement Yang, no other reason for cessation had been provided by him other than as disclosed above.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Chairman and Chief Executive Officer. Mr Clement Yang remains as the Executive Chairman of the Company.
Role and responsibilities
Leadership and governance of the Board; assist management to enhance operational efficiency.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Father to Mr William Yang, Chief Executive Officer and Executive Director of the Company; and spouse to Ms Sherry Chen Su-tien, Non-Executive Chairman of Medtecs (Taiwan) Corporation, a principal subsidiary of the Company.
Shareholding interest in the listed issuer and its subsidiaries?
24,673,285 ordinary shares (Direct Interest)
33,075,198 ordinary shares (Deemed Interest)
Past (for the last 5 years)
Please see attached.
Please see attached.
Present and Past Directorships.pdf
Total size =4K